title: COVit.102.W0.nativ.Feces.B
organism: Homo sapiens
attributes.tag: ENA first public
attributes.value: 2025-02-26
attributes.tag: External Id
attributes.value: SAMEA113400599
attributes.tag: INSDC center name
attributes.value: Institute of Clinical Molecular Biology (IKMB)
attributes.tag: INSDC last update
attributes.value: 2023-05-03T15:48:21Z
attributes.tag: INSDC status
attributes.value: public
attributes.tag: Submitter Id
attributes.value: COVit.102.W0.nativ.Feces.B
attributes.tag: age
attributes.value: 47
attributes.tag: collection date
attributes.value: 2021
attributes.tag: common name
attributes.value: human
attributes.tag: ethnicity
attributes.value: caucasian
attributes.tag: geographic location (country and/or sea)
attributes.value: Germany
attributes.tag: height (cm)
attributes.value: 173
attributes.tag: project name
attributes.value: Nicotinamide in a Prospective, Double-Blind, Randomized, Placebo-Controlled Trial for the Therapy of Signs and Symptoms of Acute Covid 71
attributes.tag: sample name
attributes.value: COVit.102.W0.nativ.Feces.B
attributes.tag: scientific_name
attributes.value: Homo sapiens
attributes.tag: sequencing method
attributes.value: Illumina Novaseq 6052
attributes.tag: sex
attributes.value: male
attributes.tag: timepoint
attributes.value: W0
attributes.tag: treatment
attributes.value: B
attributes.tag: weight (kg)
attributes.value: 93